Amit M. Oza

Researcher Next ID · RN-004301

Researcher · Medicine

Toronto, Canada

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Ovarian cancer diagnosis and treatment

PARP inhibition in cancer therapy

Cancer Genomics and Diagnostics

Endometrial and Cervical Cancer Treatments

BRCA gene mutations in cancer

Epithelial ovarian cancer
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32552-2
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1810858
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30469-2
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1611310
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1103799

No projects listed.